Hookipa Pharma Inc (HOOK)

Dec 21, 2024

The Market Doesn't Like What It Sees From HOOKIPA Pharma Inc.'s (NASDAQ:HOOK) Revenues Yet As Shares Tumble 26% - Simply Wall St

Dec 21, 2024

Dec 20, 2024

RBC downgrades HOOKIPA Pharma stock to Sector Perform as restructuring resets pipeline to preclinical - Investing.com

Dec 20, 2024

Dec 16, 2024

HOOKIPA Pharma's SWOT analysis: stock faces challenges amid pipeline shifts By Investing.com - Investing.com South Africa

Dec 16, 2024

Dec 16, 2024

Fmr LLC Has $1.47 Million Holdings in Hookipa Pharma Inc (NASDAQ:HOOK) - Defense World

Dec 16, 2024

Dec 15, 2024

HOOKIPA Pharma's SWOT analysis: stock faces challenges amid pipeline shifts - Investing.com

Dec 15, 2024

Dec 13, 2024

Hookipa Pharma stock hits 52-week low at $2.07 amid market challenges - Investing.com

Dec 13, 2024

Dec 04, 2024

HOOK (HOOKIPA Pharma) COGS-to-Revenue : 0.00 (As of Sep. 2024) - GuruFocus.com

Dec 04, 2024

Nov 25, 2024

HOOK (HOOKIPA Pharma) GF Value Rank : 2 (As of Nov. 25, 2024) - GuruFocus.com

Nov 25, 2024

Nov 25, 2024

HOOK (HOOKIPA Pharma) Debt-to-Equity : 0.04 (As of Sep. 2024) - GuruFocus.com

Nov 25, 2024

Nov 25, 2024

JMP Securities Has Lowered Expectations for Hookipa Pharma (NASDAQ:HOOK) Stock Price - Defense World

Nov 25, 2024

Nov 22, 2024

Hookipa Pharma price target lowered to $7 from $24 at JMP Securities - Yahoo Finance

Nov 22, 2024

Nov 22, 2024

Hookipa Pharma announces workforce reduction of 80%, pause of eseba-vec program - Yahoo Finance

Nov 22, 2024

Nov 22, 2024

Hookipa Pharma stock hits 52-week low at $2.62 amid market challenges - Investing.com Canada

Nov 22, 2024

Nov 22, 2024

Hookipa Pharma stock hits 52-week low at $2.62 amid market challenges By Investing.com - Investing.com South Africa

Nov 22, 2024

Nov 19, 2024

Companies Like HOOKIPA Pharma (NASDAQ:HOOK) Could Be Quite Risky - Simply Wall St

Nov 19, 2024

Nov 17, 2024

HOOKIPA Pharma Third Quarter 2024 Earnings: EPS Beats Expectations, Revenues Lag - Yahoo Finance

Nov 17, 2024

Nov 15, 2024

HOOKIPA Pharma stock target lowered, maintains outlook on strategic direction - Investing.com

Nov 15, 2024

Nov 15, 2024

RBC Capital Mkts reiterated coverage on HOOKIPA Pharma with a new price target - Quantisnow

Nov 15, 2024

Nov 15, 2024

HOOKIPA Pharma Inc (HOOK) Quarterly 10-Q Report - Quartzy

Nov 15, 2024

Nov 15, 2024

Hookipa Pharma stock hits 52-week low at $3.4 amid market challenges - Investing.com Australia

Nov 15, 2024

Nov 15, 2024

Hookipa Pharma Reports Q3 Earnings Amid Strategic Changes - TipRanks

Nov 15, 2024

Nov 14, 2024

HOOKIPA Pharma Reports Third Quarter 2024 Financial Results and Provides Recent Business Updates - The Bakersfield Californian

Nov 14, 2024

Nov 12, 2024

HOOKIPA Pharma's Eseba-vec Highlighted in SITC Late-Breaker - The Manila Times

Nov 12, 2024

Nov 11, 2024

HOOKIPA Pharma’s Eseba-vec Highlighted in SITC Late-Breaker - GlobeNewswire

Nov 11, 2024

Nov 05, 2024

HOOKIPA Pharma's SWOT analysis: stock's potential in immunotherapy market - Investing.com

Nov 05, 2024

Nov 05, 2024

HOOKIPA Pharma's SWOT analysis: stock's potential in immunotherapy market By Investing.com - Investing.com UK

Nov 05, 2024

Oct 31, 2024

HOOKIPA Pharma to Present Eseba-vec Combo in Frontline HNSCC as a Late-Breaker Poster Presentation at SITC 2024 - Quantisnow

Oct 31, 2024

Oct 31, 2024

HOOKIPA Pharma to Present Eseba-vec Combo in Frontline - GlobeNewswire

Oct 31, 2024

Oct 31, 2024

HOOKIPA commences HPV16+ cancer adjuvant care trial - Investing.com India

Oct 31, 2024

Oct 31, 2024

HOOKIPA commences HPV16+ cancer adjuvant care trial By Investing.com - Investing.com Nigeria

Oct 31, 2024

Oct 30, 2024

HOOKIPA Pharma Doses First Patients with Eseba-vec as Adjuvant Therapy in Phase 2 Investigator Lead Trial for Head & Neck Cancer - The Manila Times

Oct 30, 2024

Oct 30, 2024

HOOKIPA Pharma Doses First Patients with Eseba-vec as Adjuvant Therapy in Phase 2 Investigator - The Bakersfield Californian

Oct 30, 2024

Oct 30, 2024

HOOKIPA Pharma Doses First Patients with Eseba-vec as - GlobeNewswire

Oct 30, 2024

Oct 09, 2024

Hookipa Pharma stock hits 52-week low at $3.91 amid market challenges By Investing.com - Investing.com South Africa

Oct 09, 2024

Oct 09, 2024

Hookipa Pharma stock hits 52-week low at $3.91 amid market challenges - Investing.com

Oct 09, 2024

Oct 01, 2024

Hookipa Pharma stock hits 52-week low at $4.06 amid market challenges - Investing.com

Oct 01, 2024

Sep 30, 2024

HOOKIPA Pharma's SWOT analysis: stock's potential in cancer immunotherapy - Investing.com

Sep 30, 2024

Sep 27, 2024

HOOKIPA Pharma Inc.'s (NASDAQ:HOOK) 26% Dip In Price Shows Sentiment Is Matching Revenues - Simply Wall St

Sep 27, 2024

Sep 24, 2024

HOOKIPA presents KRAS cancer treatment data By Investing.com - Investing.com South Africa

Sep 24, 2024

Sep 24, 2024

HOOKIPA presents KRAS cancer treatment data - Investing.com India

Sep 24, 2024

Sep 24, 2024

HOOKIPA Pharma to Present Strong Preclinical HB-700 Dataset - Marketscreener.com

Sep 24, 2024